KLK3: tumorigenic or not?
By jeltsch on Wed, 12/22/2021 - 13:44
We have just published our latest review about the role of KLK3 as an activator of VEGF-C and VEGF-D in prostate cancer. Prostate cancer is one of the most common cancers in males. It is not a question whether you will get it but only when.
English